ID: ALA4781704

Max Phase: Preclinical

Molecular Formula: C15H13BrO2

Molecular Weight: 305.17

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1cccc(-c2ccc(Br)cc2)c1

Standard InChI:  InChI=1S/C15H13BrO2/c1-2-18-15(17)13-5-3-4-12(10-13)11-6-8-14(16)9-7-11/h3-10H,2H2,1H3

Standard InChI Key:  VPFBTMPYHLZHFJ-UHFFFAOYSA-N

Associated Targets(non-human)

Patatin-like phospholipase domain-containing protein 2 302 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.17Molecular Weight (Monoisotopic): 304.0099AlogP: 4.29#Rotatable Bonds: 3
Polar Surface Area: 26.30Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.75CX LogD: 4.75
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.79Np Likeness Score: -0.80

References

1. Mayer N,Schweiger M,Fuchs E,Migglautsch AK,Doler C,Grabner GF,Romauch M,Melcher MC,Zechner R,Zimmermann R,Breinbauer R.  (2020)  Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL).,  28  (16): [PMID:32690265] [10.1016/j.bmc.2020.115610]

Source